Objectives To determine the prevalence of monochorionic monoamniotic (MCMA) 
INTRODUCTION
The rate of monozygotic twinning is more stable than that of dizygotic twinning, is similar across countries and is largely unaffected by factors such as fertility treatment, increasing maternal age and obesity, which are major contributors to the increased twinning rate in recent decades [1] [2] [3] . Monochorionic (MC) twins (about 20% of all twins) are at a higher risk of perinatal death than are dichorionic twins [4] [5] [6] [7] [8] [9] due to higher prematurity rates, selective fetal growth restriction (sFGR), congenital anomalies and twin-twin transfusion syndrome (TTTS) 10, 11 . Monochorionic monoamniotic (MCMA) twins, which share an amniotic sac, are rarer, occurring in about 5% of MC pregnancies, or in one in 10 000 pregnancies overall 9 . MCMA twins carry an additional risk for perinatal death due to twin-related congenital anomalies and cord-related complications, resulting in about 15% of deaths after 20 weeks of pregnancy 12, 13 . Although perinatal mortality of MCMA twins has reduced strikingly during the last two decades compared with the extremely high rates of up to 70% reported previously 14 , it remains relatively high despite improved surveillance and care 12 . As MCMA twinning is very uncommon, randomized controlled evidence of the best management of these pregnancies is lacking 9 , and, until recently, there were no consistent recommendations on the optimal timing or method of delivery 15 . For example, the National Institute for Health and Care Excellence (NICE) guidance (England & Wales, 2011) on the antenatal management of twin and triplet pregnancies highlighted that there was insufficient evidence for effective clinical management of MCMA twin pregnancies, and that there was a need for further research to inform future provision of NHS services 15 . There is evidence from a recent multicenter cohort study 16 supporting the recommendations of the American College of Obstetricians and Gynecologists 17 and the Royal College of Obstetricians and Gynaecologists 10 for delivery of MCMA twins by Cesarean section at 32-34 weeks, but more studies of these rare multiple pregnancies are needed.
This collaborative study aimed to determine the prevalence of MCMA twin pregnancy using population-based data from the Northern Survey of Twin and Multiple Pregnancy (NorSTAMP), collected between 2000 and 2013, and to describe perinatal outcome and clinical management of these pregnancies using data from NorSTAMP and the Southwest Thames Region of London Obstetric Research Collaborative (STORK) multiple birth cohort.
METHODS

Data sources and study population, 2000-2013
NorSTAMP (established in 1998, data collection ceased 31 March 2015) captured data on multiple pregnancies of women residing in the North of England (North East and North Cumbria), which has a population of around 3 million, with 32 000 deliveries annually. Ascertainment was from the earliest antenatal examination at which a multiple pregnancy was diagnosed (recommended at 10-13 weeks in the UK 18 ) , and then at the 20-week routine ultrasound anomaly scan and at delivery (details of the notification system are presented elsewhere 19, 20 ). The records were maintained and held at the Regional Maternity Survey Office (RMSO) on a single database linked through the mother's details to other RMSO registers, including the Northern Congenital Abnormality Survey (NorCAS) 20 . The RMSO data were cross-validated annually with the Office for National Statistics (ONS) birth and death data through the external linkage built into the database. NorSTAMP collected data on maternal, obstetric and infant variables, including maternal age, index of multiple deprivation (IMD) score (an area-based measure of socioeconomic position based on the maternal residential postcode, analyzed in quintiles), pregnancy outcome (spontaneous fetal loss (< 16 completed weeks of gestation), selective feticide, miscarriage (16-23 weeks), termination of pregnancy (TOP), stillbirth (fetal death with delivery at ≥ 24 weeks of gestation), early neonatal death (0-6 days postpartum), late neonatal death (7-27 days postpartum), postneonatal death (28-365 days postpartum), alive at 1 year) and chorionicity. The final diagnosis of chorionicity for like-sex twin pregnancies is based on placental examination and histology and, when the latter are unavailable, on first-trimester ultrasound determination. Chorionicity diagnosis was verified, and detailed antenatal data were obtained from serial ultrasound examinations in the Department of Fetal Medicine database of the Royal Victoria Infirmary (RVI), the regional tertiary center in Newcastle upon Tyne. Information on zygosity as well as type of conception is not recorded in NorSTAMP 20 . Anonymized data on neonatal morbidity and care were obtained from the RVI Special Care Baby Unit (SCBU) database after linkage with obstetric ultrasound records.
The STORK multiple pregnancy cohort covers multiple pregnancies registered for routine antenatal care in 10 hospitals (listed at the end of the article) (46 500 births annually) and collects matched data on antenatal care, including ultrasound examination and pregnancy outcome from two computer databases 21 . The STORK regional hospitals, including the tertiary hospital St George's University of London (SGH), had unified protocols for antenatal management. Ultrasound examinations of MC pregnancies were performed every 2 weeks from 16 weeks until the end of the pregnancy, which included assessment of fetal biometry, amniotic fluid volume and umbilical artery Doppler waveforms. Routine antenatal admission for fetal monitoring was not advocated as these pregnancies were managed as outpatient, and were admitted mainly for obstetric indications. Neonatal outcome data were collected from SGH and other STORK hospitals where possible.
All maternity units in both the NorSTAMP and STORK cohorts follow the 2011 NICE recommendations for the antenatal management of twin and triplet pregnancies 15 . The North of England regional guidance, agreed and implemented in 2009, is consistent with the NICE principles 22 . Those units that do not have a nominated multidisciplinary team for management of MCMA twin pregnancy referred these patients to the RVI, where closer fetal surveillance was undertaken at ≥ 24 weeks. Routine practice for management of MCMA pregnancies in both RVI and STORK centers was similar in relation to frequency of ultrasound examinations (fortnightly from 16 weeks of gestation for uncomplicated pregnancies or more frequently from 24 weeks, if necessary) and prescription of a course of corticosteroids for fetal lung maturation before elective Cesarean section at about 32-34 weeks of gestation. However, in contrast to the management of MCMA pregnancies as outpatients in the STORK cohort, the RVI followed the principles of active management, which offers admission to an antenatal ward, computerized cardiotocograms three times a day, weekly ultrasound examinations for Doppler measurements and fetal biometry every 2 weeks ( Figure S1 ). The timing of active management differs depending on the gestational age at which the patient opts for elective delivery if there are concerns about fetal wellbeing, but is usually from 28 weeks.
Inclusion criteria and definitions
Only twin pregnancies with a definite diagnosis of MCMA were included in both cohorts. An initial NorSTAMP cohort was refined by excluding confirmed MC diamniotic pregnancies and complemented by additional MCMA pregnancies identified in the RVI ultrasound database. Women who declined to give consent for their confidential data to be held in the NorSTAMP database were excluded from the analyses of antenatal and neonatal data (n = 6) ( Figure 1 ). Neonatal death was defined as death during the first 0-27 days after live birth. Perinatal death included both stillbirth (fetal death at ≥ 24 weeks' gestation) and neonatal death. Twin maternity was defined as pregnancy resulting in at least one live birth or stillbirth and was used for the population-based estimate of birth prevalence and calculation of perinatal mortality.
The following indicators of fetal growth and wellbeing/development were recorded and analyzed: sFGR (fetal size discordance, defined as difference in estimated fetal weight (EFW), calculated using Hadlock formula, at the last scan before delivery, of > 20%) 10 ; intertwin birth-weight discordance (defined as difference in birth weight of > 20%); small-for-gestational age (SGA) at birth (defined as birth weight < 10 th percentile using birth weight-by-gestation and sex standards from a population of Scottish twins 23 ); and EFW-based SGA (defined as EFW < 10 th percentile using fetal growth curves from ultrasound data from the USA 24 adjusted to fit the Scottish reference dataset 23 following our previously used approach 25 ). Other variables included diagnosis of cord entanglement, TTTS, twin reversed arterial perfusion (TRAP) sequence, evidence of abnormal umbilical artery Doppler (pulsatility index > 95 th centile, absent or reversed end-diastolic flow) at the last ultrasound examination within 2 weeks before delivery and congenital anomaly diagnosed prenatally.
Data on the following neonatal outcomes were collected for infants who survived the neonatal period: respiratory distress syndrome (RDS) (yes/no); necrotizing enterocolitis (yes/no); intraventricular hemorrhage (yes/no); congenital anomaly (yes/no and, if yes, final diagnosis); sepsis (yes/no); admission to SCBU (yes/no and, if yes, number of days); mechanical ventilation (yes/no and, if yes, number of days); and continuous positive airway pressure (CPAP) (yes/no).
The North of England regional data on congenital anomalies were obtained from NorCAS, a member of the European Surveillance of Congenital Anomalies (EUROCAT). NorCAS collects data on major congenital anomalies (up to six individual congenital anomalies per case) occurring in late miscarriages (20-23 weeks' gestation), TOP for fetal anomaly (any gestational age), stillbirths and live births, whether diagnosed antenatally or not 26 . Cases are notified from multiple sources and are included when first diagnosed at any age up to 12 years 26 . All major congenital anomalies were coded according to the WHO International Classification of Diseases 10 th Revision (chapter XVII (Q00-Q99), ICD-10 27 ) and categorized using the EUROCAT criteria into group (the organ system affected), subtype (the specific condition) and syndrome 28, 29 . Cases with more than one ICD code were assigned a primary diagnosis using a hierarchical approach described elsewhere 30 . Congenital anomalies in the STORK cohort were recorded based on ultrasound diagnosis confirmed at birth.
Ethics approval and patients' consent
Informed consent was sought for women's identifying details to be held by the NorSTAMP 19, 20 . STORK Institutional Review Boards confirmed that for a retrospective analysis of routinely collected data no specific ethics consent was required.
Statistical analysis
The MCMA twin birth prevalence for 2000-2013 was estimated as the number of MCMA twin maternities for the North of England population per 1000 pregnancies resulting in registered births (live or stillbirths), obtained from the ONS. The total prevalence was estimated using the number of MCMA twin pregnancies per 1000 twin pregnancies recorded in NorSTAMP. Descriptive statistics were used to characterize and compare baseline characteristics of MCMA twin pregnancies between the NorSTAMP and STORK cohorts. Differences in the distributions of continuous variables were compared using the Mann-Whitney U-test and medians with interquartile range (IQR) were reported. Percentages were presented for categorical variables and compared using the χ 2 test or Fisher's exact test. Perinatal mortality was calculated using combined NorSTAMP and STORK data per 1000 individuals from MCMA maternities, including those with one fetal loss before 24 weeks' gestation. Antenatal parameters and obstetric outcome were analyzed using data for stillbirths and live births, while the analysis of neonatal outcome was restricted to neonatal survivors.
All analyses were performed using SPSS Statistics for Windows, version 21.0 (IBM Corp., Armonk, NY, USA). P < 0.05 was considered statistically significant.
RESULTS
Prevalence of MCMA twin pregnancy
Overall, in the North of England region during 2000-2013, there were 59 MCMA twin pregnancies confirmed to be MCMA by either both ultrasound examination and placental pathology (54.2%), when available, or first-trimester ultrasound examination only (45.8%), including pregnancies resulting in early fetal loss of both cotwins (n = 22) (Figure 1 ). The estimated MCMA birth prevalence was 0.08 (37/442 624) per 1000 pregnancies overall (singleton and multiple), or 5.7 (37/6536) per 1000 twin pregnancies resulting in registered births. The total prevalence was 8.2 per 1000 twin pregnancies (59/7170). Table 1 shows baseline characteristics for 85 MCMA pregnancies (excluding conjoined twins) in the NorSTAMP and STORK cohorts. There were no significant differences in median maternal BMI at booking, as well as the percentage of nulliparous women, prenatal diagnosis of chorionicity or delivery by Cesarean section between the two cohorts. However, in the STORK cohort, the women were older and the percentage of pregnancies with female fetal sex was significantly higher, while the percentage of women living in the most deprived areas (IMD 5 th quintile) was significantly higher in the NorSTAMP cohort (Table 1) . Table 2 shows pregnancy outcome for these 85 pregnancies. Thirty pregnancies (31.8% (54/170) of fetuses) resulted in fetal loss before 24 weeks' gestation, including spontaneous intrauterine death (IUD) (n = 17) or TOP (n = 7) of both fetuses, and six pregnancies with either a single spontaneous IUD (n = 3) or selective termination (n = 3). Among the other 55 pregnancies, the majority (n = 49) resulted in live birth of both twins (in 43 (88%); both survived the neonatal period), while six resulted in either a single or double IUD at ≥ 24 weeks. Table 3 shows stillbirth and neonatal mortality rates among 116 MCMA twins of pregnancies with registered births and a known cause of death in cases of perinatal death in the NorSTAMP and the STORK cohorts. The overall perinatal mortality rate was 14.7%, differing according to gestational age window: 69.2%, 11.8% and 4.5% at < 30, 30-32 and ≥ 33 weeks' gestation, respectively. When fetuses in ongoing pregnancies were used as the denominator, gestational age-specific risk of perinatal mortality was 7.9%, 4.0% and 4.5% for < 30, 30-32 and ≥ 33 weeks, respectively. The excess perinatal mortality at < 30 weeks was attributed mainly to neonatal deaths due to extreme prematurity as a result of spontaneous labor at 22-26 weeks (n = 6; among these, one twin had a complex congenital heart defect) and antepartum stillbirths at 24 and 27 weeks (n = 3). According to the postmortem examination, antepartum hypoxia was the leading cause of stillbirth (3/8 due to presumed cord entanglement) with double IUD in two pregnancies (Tables 2 and 3 ). All six pregnancies resulting in a stillbirth were managed as outpatients because this was routine practice (three cases of single IUDs in the STORK cohort), because an IUD occurred 18 ). ‡ ‡Both fetuses affected by congenital anomaly in three pregnancies. § §Pregnancies resulting in at least one registered birth. ¶ ¶Eight women had spontaneous vertex delivery (two resulted in antepartum stillbirth of both fetuses, three births were at < 28 weeks of gestation (one at 22 and two at 26 weeks) and three pregnancies had early fetal loss). #One pregnancy with single antepartum stillbirth had vaginal delivery. BMI, body mass index; N/A, not applicable.
Pregnancy outcome of MCMA twin pregnancy
Perinatal mortality in MCMA twins
at < 28 weeks, before the usual timing of offering active/inpatient management to NorSTAMP patients (one case of double IUD at 24 weeks and one of a single IUD at 27 weeks), or because ultrasound examinations were normal throughout pregnancy, including the last one (one case had a normal examination at 31 + 1 followed by double IUD at 32 weeks). There were no predictive factors for IUD in these pregnancies, such as major congenital anomalies, abnormal umbilical artery Doppler or growth discordance recorded on ultrasound examinations throughout pregnancy. In one pregnancy, sFGR was diagnosed at birth, with the dead fetus having a 31% lower birth weight. Figure 1 shows the derivation of the cohort of 45 MCMA pregnancies in the NorSTAMP and STORK cohorts with survival beyond 24 weeks' gestation that were eligible for analysis. Table 4 shows antenatal indicators of fetal development and wellbeing, and obstetric outcome for live and stillborn MCMA twins whose mothers gave consent for their confidential data to be held in the NorSTAMP database. In over two-thirds (33/45, 73.3%) of pregnancies, MCMA placentation was diagnosed in the first trimester of pregnancy (≤ 13 weeks' gestation). None of the fetuses for which umbilical artery Doppler was recorded at the last examination ≤ 2 weeks before delivery (n = 53) had an abnormal parameter, despite the majority (86%) having a definite diagnosis of cord entanglement. However, in one pregnancy with double IUD, there were normal Doppler parameters and no apparent knotting between the adjacent cords 1 week before double IUD was diagnosed. In all five pregnancies complicated by a major congenital anomaly, the diagnosis was made on an antenatal ultrasound examination. Intertwin discordance in EFW at the last examination ≤ 2 weeks before delivery 
Antenatal parameters and obstetric outcomes of MCMA twins
Neonatal morbidity of MCMA twins
Five neonatal deaths were excluded from the analysis of neonatal morbidity (Table 4) . Most twins (74% of 73 neonatal survivors) were admitted to SCBU, with an average stay of around 17 days and RDS as the most common diagnosis (58.7%). For infants with RDS, mechanical ventilation and/or CPAP were used for respiratory support in 15% and 55% of infants, respectively.
DISCUSSION
Main findings
In this study, we estimated the prevalence of MCMA twin pregnancies in an English region using population-based NorSTAMP data, 2000-2013, to inform future provision of obstetric and neonatal services. The prevalence of MCMA twin pregnancies in the North of England region was 8.2 per 1000 twin pregnancies; the birth prevalence was 0.08 per 1000 pregnancies overall. Over a third of pregnancies resulted in fetal loss < 24 weeks of gestation (31.8% of fetuses). Overall perinatal mortality was 14.7%. The majority of MCMA twins were delivered by elective Cesarean section at a median of 33 gestational weeks. Neonatal morbidity was associated mostly with conditions related to preterm delivery, with RDS being the most common diagnosis.
Strengths and limitations
This study used multicenter data sources from 11 NorSTAMP and 10 STORK maternity units.
NorSTAMP was unique in Europe in ascertaining multiple pregnancies from the earliest antenatal examination. Accuracy of chorionicity diagnosis was ensured at the first-trimester ultrasound examination by an experienced fetal medicine ultrasonographer in both the NorSTAMP and STORK tertiary centers. Only twin pregnancies with a definite MCMA diagnosis were included in the analysis. Pregnancies with conjoined twins are not included. *This cause of death was specified if definite postmortem diagnosis was available. AP, antepartum; CHD, congenital heart disease; EDF, end-diastolic flow on umbilical artery Doppler; ENND, early neonatal death; FGR, fetal growth restriction; HMD, hyaline membrane disease; IUD, intrauterine death; IVH, intraventricular hemorrhage; NT, nuchal translucency; PROM, premature rupture of membranes; pURSM, partial urorectal septum malformation (or 'persistent cloaca'); TOP, termination of pregnancy; TRAP, twin reversed arterial perfusion; TTTS, twin-twin transfusion syndrome. *Stillbirth rate calculated per 1000 registered births in MCMA twin maternities, excluding single fetal losses < 24 weeks of gestation (n = 6) in pregnancies resulting in a single live birth. †Perinatal deaths include stillbirths (≥ 24 weeks of gestation) and neonatal deaths (0-27 days). ‡Including three cases of cord entanglement. §Prematurity category includes related WHO International Classification of Diseases 10 th Revision 27 codes (chapter XVI): severe pulmonary immaturity, hyaline membrane disease and intraventricular hemorrhage. ¶Four pregnancies resulted in neonatal deaths following delivery at < 27 weeks of gestation: two cotwins delivered at 22 weeks of gestation (both early neonatal deaths (ENNDs)), one ENND following delivery at 25 weeks, two cotwins (ENND with complex congenital heart disease and late neonatal death due to severe hyaline membrane disease) and one single late neonatal death following delivery at 26 weeks.
This study analyzed early fetal losses in addition to perinatal outcomes, including congenital anomalies, and collected detailed antenatal data from the serial ultrasound examinations linked to the outcome data. In the North of England region, congenital anomaly data were collected in the population-based NorCAS, linked with NorSTAMP, assuring completeness and accuracy of congenital anomaly data. This study also has some limitations. The retrospective nature of the study led to challenges in obtaining all the necessary detail on the antenatal and neonatal data for all pregnancies in both collaborative centers, particularly for the early study years, resulting in incomplete follow-up and some missing data, including RVI in/outpatient management. While both centers followed similar regionspecific unified protocols for the management of MCMA twin pregnancies, consistent during the study period, there were some differences in relation to out-and inpatient antenatal management. Nevertheless, this did not significantly affect the timing of elective delivery, although gestational age at delivery was non-significantly lower among the NorSTAMP patients, possibly due to active management from about 28 weeks at the RVI. There was also no effect on outcome as all pregnancies resulting in stillbirths were managed as outpatient and most neonatal deaths resulted from extreme prematurity due to preterm spontaneous labor or from a major congenital anomaly. Although the current study is one of the largest studies on MCMA twins in Europe, the sample size was still small.
Interpretation and comparison with published studies
Female fetuses predominated in MCMA pairs with known fetal sex (67% from combined NorSTAMP and STORK data), consistent with previous studies 12, 13, [31] [32] [33] [34] reporting between 55%
13 and 92% 34 . The percentage of female MCMA pairs was significantly higher in the STORK cohort, likely due to the three-fold greater percentage of pregnancies with missing sex among early fetal losses (34.2% vs 10.6% in NorSTAMP), assuming a proposed higher rate of early fetal mortality among male MCMA fetuses 31 . Expected differences between the cohorts existed in maternal age and deprivation scores. Thus, the reported higher maternal age in the STORK cohort is attributable to the known geographical differences in maternal age distribution between London and North East England (26.6% and 15.1%, respectively, of mothers aged ≥ 35 years and a two-fold lower percentage of mothers < 25 years in London (2013 data)) 35 . A significantly higher percentage of women from the most deprived residential areas were found in the NorSTAMP cohort as the North of England region has a large proportion of areas amongst the most deprived in England 36 . Our estimated MCMA twin pregnancy prevalence of 0.8 per 10 000 pregnancies overall in the North of England region is consistent with published estimates 9 . It is encouraging that, in the present study, as in the largest study to date by Van Mieghem et al. (193 MCMA pregnancies) 16 , MCMA pregnancies were diagnosed much earlier (at about 13 weeks' gestation) than in the past 37 , which gives more room for earlier fetal monitoring and management. The rate of spontaneous IUD (16.3%) in the abovementioned study 16 was comparable with that in the current study (23% after excluding pregnancies with TRAP sequence, as was done in that study 16 ). Pregnancies affected by a major congenital anomaly in our study constituted 27%, similar to the 23% 16 and 28% 37 reported in previous studies.
Perinatal mortality in our study (14.7%) was almost identical to the total perinatal mortality reported by Baxi and Walsh in 2010 34 for eight studies (15%) 12, 32, 33, [37] [38] [39] [40] [41] , being more similar (15-19%) to that in larger multicenter studies 12, 39 , as well as to that (13.9%) reported by a more recent Japanese study (n = 101) 13 . Perinatal mortality for non-anomalous MCMA twins in our study (12.4%) also corresponds with the total perinatal mortality for non-anomalous pregnancies reported by six studies in Baxi and Walsh's review (12.7%) 34 . Neonatal mortality (8.3%) in our study was also comparable with that reported by Hack et al. in 2009 12 (10%) and by Van Mieghem et al. 16 (5.8%).
Implications and conclusions
There is no consistency regarding optimal timing of elective delivery of MCMA twin pregnancies and the effect Data are presented as median (interquartile range) or n/N (%). All numbers expressed as percentage of pregnancies, unless indicated otherwise. *Only estimated fetal weights (EFW) examined ≤ 2 weeks prior to delivery are included (n = 25). †EFW < 10 th percentile was calculated to define small-for-gestational age (SGA) in utero using fetal growth curves from the USA ultrasound data 24 adjusted to fit Scottish reference dataset 23 . ‡In one pregnancy resulting in early death of both neonates (22 weeks of gestation) there was no comment on cord condition. §Number expressed as percentage of individual twins. ¶Only Doppler parameters examined ≤ 2 weeks prior to delivery are included. **n = 44. † †Birth weight < 10 th percentile was calculated to define SGA infants using birth weight-by-gestation and sex standards from population of Scottish twins 23 . ‡ ‡Data for 73 neonatal survivors (STORK pregnancies with missing data on neonatal outcome are excluded (n = 4)). § §Data missing for seven of 29 first twins and for nine of 25 second twins admitted to SCBU. ¶ ¶Including only cases with complete data for this parameter. CPAP, continuous positive airway pressure; CS, Cesarean section; GA, gestational age; SCBU, special care baby unit; sFGR, selective fetal growth restriction, defined as difference in EFW of >20% 10 ; TTTS, twin-twin transfusion syndrome; US, ultrasound. of cord entanglement on perinatal outcome. Some advocate expectant management after 20 weeks, predicting a good prognosis for uncomplicated MCMA twin pregnancies despite the existence of cord entanglement 42, 43 . This would suggest reassessing the practice of elective very preterm delivery (≤ 32 weeks) 42 . There is evidence that IUD in MCMA twins can occur after 32 weeks 12, 32, 39, 40 , which is also confirmed by our findings. Whilst most MCMA pregnancies surviving beyond 24 weeks' gestation with a definite diagnosis of cord entanglement had good perinatal outcome, the risk for fetal death after 32 weeks was shown to be 4 in 100 MCMA pregnancies compared with 1 in 100 for neonatal death associated with preterm birth at 32 weeks 12, 44 . The largest study to date also demonstrated that the prospective risk of IUD in MCMA twins outweighs the risk of a non-respiratory neonatal complication at 32 + 4 weeks of gestation, concluding that optimal timing for elective delivery is about 33 gestational weeks 16 . Our study confirms that the perinatal survival of MCMA twins has improved compared with that in previous decades, presumably due to early diagnosis, careful fetal surveillance and elective birth by Cesarean section at 32-34 weeks. Fetal loss at < 24 weeks is common as a result of spontaneous loss and congenital anomalies. Future research investigating pregnancy outcome and antenatal development of these rare high-risk twin pregnancies should aim at a multicenter prospective approach to establish survival from the first trimester and the consequences of early elective delivery, including long-term developmental outcome.
